Table 7.
The localization of differentially expressed fat–related genes
Alignments | Gene Symbol | Transcript ID | Gene ontology |
---|---|---|---|
chrZ:53399697-53408327 |
LPL, ENSGALG00000015425 |
NM_205282 |
GO:0004465 lipoprotein lipase activity; |
GO:0004806 triacylglycerol lipase activity; | |||
GO:0006629 lipid metabolism; | |||
chr4:53309684-53311980 |
SULT1B1, SULT1B1 |
NM_204545 |
GO:0006629 lipid metabolism; |
GO:0008202 steroid metabolism; | |||
chr28:1247898-1259038 |
ACSBG2(RCJMB04_9i11) |
NM_001012846 |
006629 lipid metabolism; |
GO:0006631 fatty acid metabolism; | |||
chr15:4477440-4512637 |
AACS, ENSGALG00000002899 |
NM_001006184 |
GO:0006629 lipid metabolism; |
GO:0006631 fatty acid metabolism; | |||
GO:0005829 cytosol | |||
chr1:71256654-71270462 |
PNPLA3 |
XM_416457 |
GO:0006629 lipid metabolism; |
GO:0006629 lipid metabolism; | |||
GO:0016042 lipid catabolism | |||
chr7:2296059-2312305 |
FRZB, ENSGALG00000002763 |
NM_204772 |
GO:0017147 Wnt-protein binding; |
GO:0007275 development; | |||
GO:0016055 Wnt receptor signaling pathway | |||
chr15:8372896-8375331 |
DDT(RCJMB04_2c16) |
NM_001030667 |
GO:0006583 melanin biosynthesis from tyrosine; |
chr1:132739051132944192 |
DHRSX |
XM_001232713 |
GO:0055114 oxidation reduction |
chr7:6879282-6888069 |
LSS |
NM_001006514 |
GO:0006695 cholesterol biosynthesis |
chr7:22713218-22757360 |
DPP4 |
NM_001031255 |
GO:0005515 protein binding; |
GO:0008239 dipeptidyl-peptidase activity; | |||
GO:0042803 protein homodimerization activity; | |||
chr13:13578206-13590970 |
MGAT4B |
XM_414605 |
GO:0005975 carbohydrate metabolism; |
chrZ:23472632-23474241 |
HMGCR, ENSGALG00000014948 |
NM_204485 |
GO:0004420 hydroxymethylglutaryl-CoA reductase (NADPH) activity; |
GO:0016491 oxidoreductase activity; | |||
GO:0050661 NADP binding; | |||
chr5:24711230-24725772 |
ENSGALG00000008078, FUT8 |
NM_001004766 |
GO:0008424 glycoprotein 6-alpha-L-fucosyltransferase activity; |
GO:0046921 alpha(1,6)-fucosyltransferase activity; | |||
GO:0007179 transforming growth factor beta receptor signaling pathway | |||
chr6:28077530-28103087 |
GPAM |
XM_421757 |
GO:0006631 fatty acid metabolism; |
GO:0019432 triacylglycerol biosynthesis; | |||
GO:0040018 positive regulation of body size; | |||
chr20:3629311-3638107 |
SGK2 |
XM_417346;CR387909 |
GO:0004713 protein-tyrosine kinase activity; |
GO:0005524 ATP binding; | |||
chr3:34793675-34819927 |
PRKD3 |
XM_419526 |
GO:0004713 protein-tyrosine kinase activity; |
GO:0005524 ATP binding; | |||
chr20:2633184-2647420 |
ACSS2 |
XM_417342 |
GO:0006085 acetyl-CoA biosynthesis; |
Chr1: 64269656-64276867 |
LOC418170 |
XM_416401 |
GO:0055114 oxidation reduction |
chr6:17648418-17654233 |
CYP2C45 |
SNM_001001752 |
GO:0055114 oxidation reduction |
chr4:11367346-11377074 |
NSDHL |
XM_420279 |
GO:0005975 carbohydrate metabolism; |
GO:0008203 cholesterol metabolism; | |||
chrUn_random:7545445-7546725 |
FDPS |
XM_422855 |
GO:0006695 cholesterol biosynthesis |
chr2:144322566-144334593 |
SQLE |
NM_001030953 |
GO:0055114 oxidation reduction; |
chr8:26011324-26019531 |
DHCR24 |
NM_001031288 |
GO:0016125 sterol metabolism; |
chr1:64293981-64312331 |
AKR1B1 |
XR_026805 |
GO:0055114 oxidation reduction |
chr1:118069255-119072613 |
DMD |
NM_205299 |
GO:0007519 striated muscle development; cytoplasm; |
GO:0016010 dystrophin-associated glycoprotein complex; | |||
GO:0045121 lipid raft; | |||
chr18:4906222-4942593 |
FASN, ENSGALG00000002747 |
NM_205155;J02839 |
GO:0000036 acyl carrier activity; |
GO:0004312 fatty-acid synthase activity; | |||
GO:0006633 fatty acid biosynthesis; | |||
chr4:59493262-59560594 |
ELOVL6 |
|
GO:0006633 fatty acid biosynthesis |
chr6:11960338-11966483 |
HKDC1 |
XM_421579 |
GO:0005524 ATP binding; |
GO:0005975 carbohydrate metabolism; | |||
GO:0006096 glycolysis; | |||
chr2:64406040-64411831 |
GCNT2 |
XM_426036;XM_418950 |
GO:0008375 acetylglucosaminyltransferase activity; |
chr1:98522850-98669948 | GBE1 | XM_425536 | GO:0005975 carbohydrate metabolism |